Pan Drugs Limited - pharma in Vadodara, Gujarat, India. FY 2026 financials & compliance.
CIN U24230GJ1993PLC020671 Incorporated 16 November 1993 ROC Ahmedabad HQ Vadodara, Gujarat, India
Active Public Limited Company pharma MSME · Medium
Data last updated
Revenue · FY 2025
₹1.12 Cr
▼ 19% YoY
Net profit · FY 2025
₹2.37 Lakh
Net margin 2.1%
EBITDA · FY 2025
₹19.06 Lakh
EBITDA margin 17%
Authorised capital
₹5.5 Cr
Registered with MCA
Paid-up capital
₹3.14 Cr
Issued & subscribed
Open charges
₹28.43 Lakh
Satisfied ₹45.08 Cr
Company age
33 yrs
Est. 1993
Employees · EPFO
34
Provident fund records

About Pan Drugs Limited

Data last updated:

Pan Drugs Limited is a public limited company based in Vadodara, Gujarat, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 16 November 1993 and has been in existence for over 33 years.

The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U24230GJ1993PLC020671. Its GSTIN is 24AABCP1997K1Z3 (Gujarat).

The company has an authorised share capital of ₹5.5 Cr and a paid-up capital of ₹3.14 Cr. It is led by directors including Atul Natwarlal Pandya and Parag Vamanray Raval.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 301 312 World Trade Center Sayajigunj, Vadodara, Gujarat, India – 390007.

As per the financials filed for FY 2025, the company reported a revenue of ₹1.12 Cr, a decline of 19% compared to the previous year. For the same year it recorded a net profit of ₹2.37 Lakh (net margin 2.1%) and EBITDA of ₹19.06 Lakh (EBITDA margin 17%). Revenue has declined at a compounded annual rate (CAGR) of 77% over three years and 50% over five years.

The company has about 34 employees on its provident fund (EPFO) records.

The company is associated with 1 brand: Pan Drugs. As per MCA filings, the company has open charges of ₹28.43 Lakh and satisfied charges of ₹45.08 Cr on record. Court records list 66 cases involving the company, including 39 filed by the company and 27 filed against it; 7 cases are pending.

Pan Drugs Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-GJ-24-0023366). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website pandrugsltd.com.

Company details

CIN U24230GJ1993PLC020671
Registration Number 020671
Incorporation Date 16 November 1993
ROC Ahmedabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-GJ-24-0023366

CIN history

Pan Drugs has one previous CIN (Corporate Identification Number): L24230GJ1993PLC020671. The current CIN is U24230GJ1993PLC020671, which is the unique identifier assigned by the Registrar of Companies.

CINStatus
U24230GJ1993PLC020671Current
L24230GJ1993PLC020671Previous

Recognitions & Rankings of Pan Drugs

MSME (Udyam registered) Ministry of MSME
Category
Medium (2024-25)
Udyam number
UDYAM-GJ-24-0023366

Contact details

Pan Drugs Limited's registered office is in Vadodara, Gujarat. Its website is pandrugsltd.com. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    301 312 World Trade Center Sayajigunj, Vadodara, Gujarat, India – 390007
  • Industry
    Pharma, Drug Formulation & Development, API Manufacturers

To see the full contact details of Pan Drugs Limited, buy the company report.

Comprehensive company report
Pan Drugs Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Brands

Pan Drugs operates one associated brand: Pan Drugs. Each brand links to its own profile.

BrandDescriptionWebsite
Manufactures generic Active Pharmaceutical Ingredients and offers contract services worldwide.pandrugsltd.com

Business activity

The main business activity of Pan Drugs is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products

To see the full business activity and turnover split of Pan Drugs Limited, buy the company report.

Financials of Pan Drugs Limited

FY 2025 filings available

Pan Drugs Limited reported revenue of ₹1.12 Cr (down 19% YoY) for FY 2025.

Revenue · FY 2025
₹1.12 Cr ▼ 19%
Net profit · FY 2025
₹2.37 Lakh margin 2.1%
EBITDA · FY 2025
₹19.06 Lakh margin 17%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▼ 19%
3 years · compounded
▼ 77%
5 years · compounded
▼ 50%
EBITDA CAGR growth
1 year
▲ 687%
3 years · compounded
▼ 50%
5 years · compounded
▼ 53%

Revenue has declined at a compounded annual rate (CAGR) of 50% over five years, including a 19% fall in the latest year. EBITDA rose 687% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹19.06 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)₹2.37 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin17%
Net Profit Margin2.1%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Pan Drugs Limited, buy the company report.

Board of directors of Pan Drugs Limited

Pan Drugs has 5 current directors and 10 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Atul Natwarlal PandyaDirector31 Jul 200719 Years 3 MonthsCurrent
Parag Vamanray RavalDirector10 May 20188 Years 5 MonthsCurrent
Kamal Natwarlal PandyaDirector16 Nov 199332 Years 11 MonthsCurrent
Hemant Gajanand UpadhyayDirector31 May 200323 Years 5 MonthsCurrent
Rushiraj Atulbhai PandyaAdditional Director10 Mar 20251 Years 7 MonthsCurrent

Auditor

Pan Drugs Limited is audited by K.J. Shah & Co for the financial year 2023.

Auditor firmFinancial yearFirm registration number
K.J. Shah & CoFY 2023132369W

Shareholding

The shareholding of Pan Drugs Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2023FY 2022FY 2021FY 2020FY 2019
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Pan Drugs Limited, buy the company report.

Charges & borrowings

Open charges
₹28.43 Lakh
Satisfied charges
₹45.08 Cr
Breakdown by lending institutions
Hdfc Bank Limited₹0.28 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
31 Dec 2021100527683Hdfc Bank Limited₹28.43 LakhOpen
20 Oct 200180064699State Band of Hydrabad₹3 CrSatisfied
13 Sep 200090099257Anyonya Co - Operative Bank Ltd.₹1 CrSatisfied
31 Mar 200090096656Idbi Bank Ltd.₹11 CrSatisfied
03 Dec 199990096643Idbi Bank Ltd.₹8.5 CrSatisfied

To see the full charge records of Pan Drugs Limited, buy the company report.

Total charge records: 13 View all charges

MSME payment delays

Pan Drugs Limited has 8 MSME Form 1 returns on record between 2019 and 2024, listing 195 overdue payments to 80 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.

Suppliers with reported dues (5 of 80)

SupplierAmount dueDue sinceReported on
Shiv Bio Coal
Delta Engineers
an individual supplier
an individual supplier
Halol Packing Wood Industries

To see the full MSME payment records of Pan Drugs Limited, buy the company report.

Individuals and sole proprietors among the suppliers are not named.

Employees & EPFO

Pan Drugs Limited has a workforce of 34 employees on its EPFO records as of Mar 29, 2024, across 2 active EPFO establishments.

Employee count
34
Active EPFO establishments
2
Employee growth
9.68%

GST

Pan Drugs has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
24AABCP1997K1Z3GujaratActive01 Jul 2017

To see the full GST registrations and return filing status of Pan Drugs Limited, buy the company report.

Recent activity

Pan Drugs Limited has 14 board changes on record since 1993: 5 appointments and 9 cessations. The latest: Rushiraj Atulbhai Pandya was appointed as Additional Director on 10 Mar 2025.

AGM
Pan Drugs Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Pan Drugs Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad.
Appointed
Rushiraj Atulbhai Pandya was appointed as Additional Director.
Ceased
Kamal Natwarlal Pandya ceased to be Managing Director.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 0.28 Cr with Charge ID 100527683 was registered on 31 Dec 2021.
Charges
A charge registered on 13 Sep 2000 via Charge ID 90099257 with Anyonya Co - Operative Bank Ltd. was fully satisfied on 23 Jan 2020.
Charges
A charge registered on 15 Oct 1998 via Charge ID 90096565 with Anyonya Sahakari Mandli Co - Op. Bank Ltd. was fully satisfied on 23 Jan 2020.
Charges
A charge registered on 28 Oct 1996 via Charge ID 90098501 with Anyonya Sahayakari Mandli Co - Operative Bank Ltd. was fully satisfied on 23 Jan 2020.
Charges
A charge registered on 24 Oct 1996 via Charge ID 90096437 with Anyonya Co - Op. Bank Ltd. was fully satisfied on 23 Jan 2020.
Appointed
Parag Vamanray Raval was appointed as Director.
Ceased
Braahmoy Caet Dasny Vaz ceased to be Director.
Ceased
Parag Vamanray Raval ceased to be Director.

37 earlier events are in the company report.

Frequently asked questions

Pan Drugs is an active public limited company based in Vadodara, Gujarat, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 16 November 1993 (33+ years old) and is registered under CIN U24230GJ1993PLC020671.

Pan Drugs has 5 current directors:

The latest financial statements of Pan Drugs on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of Pan Drugs is 24AABCP1997K1Z3, registered in Gujarat.

The CIN (Corporate Identification Number) of Pan Drugs is U24230GJ1993PLC020671. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Pan Drugs has 66 court cases on record: 39 filed by the company and 27 filed against it. 7 are pending. Most are in the district courts.

Pan Drugs was incorporated on 16 November 1993, making it 33+ years old. It is registered with the Registrar of Companies, Ahmedabad.

Rushiraj Atulbhai Pandya was appointed as Additional Director on 10 Mar 2025. Kamal Natwarlal Pandya ceased to be Managing Director on 30 Sep 2023. Parag Vamanray Raval was appointed as Director on 10 May 2018. Pan Drugs has 14 board changes on record in total.

Yes, Pan Drugs is registered as a medium enterprise under Udyam registration (number: UDYAM-GJ-24-0023366).

Pan Drugs has 8 MSME Form 1 returns on record between 2019 and 2024, listing 195 overdue payments to 80 micro and small suppliers. The latest return was filed on 04 Jun 2024.

Pan Drugs can be reached through the website pandrugsltd.com. Its registered office is in Vadodara, Gujarat, India.